Péter Sandy
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- PI3K/AKT/mTOR signaling in cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- Protein Degradation and Inhibitors 8
- Ubiquitin and proteasome pathways 5
- RNA Interference and Gene Delivery 4
- Protein Kinase Regulation and GTPase Signaling 4
- RNA modifications and cancer 4
- Cancer-related gene regulation 3
- Oncology 11
- Cancer-related Molecular Pathways 5
- Co-authors
- Tyler Jacks (5 shared papers)Srividya Balasubramanian (2 shared papers)Louise Bergeron (2 shared papers)Barbara M. Bryant (2 shared papers)Robert J. Sims (2 shared papers)Jennifer A. Mertz (2 shared papers)Andrew R. Conery (2 shared papers)Deanna A. Mele (1 shared paper)
- Journals
- Cancer Research (3 papers)Journal of Biological Chemistry (3 papers)Cell (2 papers)Proceedings of the National Academy of Sciences (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Péter Sandy
27 papers receiving 3.6k citations
Péter Sandy's Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 580
- Molecular Biology 3.0k
- Oncology 942
- Cancer Research 399
- Genetics 162
Countries citing papers authored by Péter Sandy
This map shows the geographic impact of Péter Sandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Sandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Sandy more than expected).
Fields of papers citing papers by Péter Sandy
This network shows the impact of papers produced by Péter Sandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Sandy. The network helps show where Péter Sandy may publish in the future.
Co-authors
The 25 scholars most cited alongside Péter Sandy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting MYC dependence in cancer by inhibiting BET bromodomains Hit paper breakdown → | 2011 | 908 |
| 2 | AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer | 2009 | 441 |
| 3 | 1999 | 437 | |
| 4 | 2009 | 436 | |
| 5 | 2013 | 261 | |
| 6 | 2014 | 146 | |
| 7 | 2003 | 141 | |
| 8 | 2013 | 119 | |
| 9 | 2005 | 104 | |
| 10 | 2016 | 89 | |
| 11 | 2011 | 86 | |
| 12 | 2003 | 80 | |
| 13 | 2014 | 80 | |
| 14 | 2004 | 77 | |
| 15 | 2003 | 72 | |
| 16 | 2014 | 53 | |
| 17 | 2000 | 40 | |
| 18 | 2021 | 14 | |
| 19 | 2010 | 13 | |
| 20 | 2007 | 11 |
About Péter Sandy
Péter Sandy is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Immunology, having authored 28 papers that have together received 3.6k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (5 papers), RNA Interference and Gene Delivery (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Multiple Myeloma Research and Treatments (4 papers), RNA modifications and cancer (4 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Hematology (580 citations), Molecular Biology (3.0k citations), Oncology (942 citations), Cancer Research (399 citations) and Genetics (162 citations). Péter Sandy has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Tyler Jacks, Srividya Balasubramanian, Louise Bergeron, Barbara M. Bryant, Robert J. Sims, Jennifer A. Mertz, Andrew R. Conery, Deanna A. Mele, Eric S. Lander and Sebastian Hoersch. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Cell, Proceedings of the National Academy of Sciences and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.